Evidence map›Paper›PMID 30071885›Full record

ArticleParasites & vectors2018

Laboratory evaluation of the efficacy of lotilaner (Credelio™) against Haemaphysalis longicornis infestations of dogs.

Hiroshi Otaki, Junko Sonobe, Martin Murphy, Daniela Cavalleri, Wolfgang Seewald, Jason Drake, Steve Nanchen

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Efficacy of lotilaner (CredelioParasites & vectors · 2026
    Article
  3. Article
  4. Efficacy of Credelio QuattroParasites & vectors · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Efficacy of sarolaner (SimparicaParasites & vectors · 2019
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Hiroshi OtakiElanco Japan K. K., 4-15-1 Akasaka, Minato-ku, Tokyo, 107-0052, Japan.
Junko SonobeElanco Japan K. K., 4-15-1 Akasaka, Minato-ku, Tokyo, 107-0052, Japan.
Martin MurphyElanco Animal Health, Mattenstrasse 24a, CH-4058, Basel, Switzerland.
Daniela CavalleriElanco Animal Health, Mattenstrasse 24a, CH-4058, Basel, Switzerland.
Wolfgang SeewaldElanco Animal Health, Mattenstrasse 24a, CH-4058, Basel, Switzerland.
Jason DrakeElanco Animal Health, 2500 Innovation Way, Greenfield, IN, 46140, USA. drake_jon_j@elanco.com.ORCID http://orcid.org/0000-0001-6203-0852
Steve NanchenElanco Animal Health, Mattenstrasse 24a, CH-4058, Basel, Switzerland.
MSD K.K. (Japan) · JPElanco (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThroughout Japan, Korea and China, Haemaphysalis longicornis ticks are vectors of Babesia gibsoni, which causes severe and progressive anemia in dogs. This study evaluated the efficacy of a single administration of lotilaner flavored chewable tablets (Credelio

methodsTwenty-two healthy Beagles were ranked in descending order of counts of H. longicornis completed 48 h after challenge on Day -7. The 16 dogs with the highest live tick counts were blocked into pairs and within pairs randomized to either lotilaner-treatment at a minimum dose rate of 20 mg/kg or sham-treated controls. Treatment was administered within 30 ± 5 min following feeding on Day 0. Infestations with 50 unfed adult H. longicornis were completed on Days -2, 7, 14, 21, 28 and 35. Elizabethan collars were placed for 48 (± 2) h after each infestation and a T-shirt was placed on each dog to facilitate attachment. Ticks were counted in situ 12 and 24 h post-treatment and counted and removed after an additional 24 h (48 h after treatment) and 48 h after each post-treatment infestation. Dogs were sedated for tick challenges and counts. Live attached ticks on each dog were counted for efficacy assessments. Lotilaner was considered effective if the average tick attachment rate in the control group was at least 20%, if there was a statistically significant difference (P < 0.05) in mean tick counts between treated and control groups, and if the lotilaner-treated group had a calculated efficacy of at least 90%.

resultsAverage control group retention of the H. longicornis challenge exceeded 20% at each assessment. Lotilaner started killing H. longicornis ticks quickly, achieving 57.4% efficacy within 12 h. At 48 h post-treatment, and following each subsequent infestation, between-group differences in mean H. longicornis counts were significant (P < 0.0001). From 48 h post-treatment, through the final assessment on Day 37, lotilaner efficacy remained greater than 95%, including on Day 37 when efficacy was 98.4%.

conclusionLotilaner, administered to dogs orally at a minimum dose rate of 20 mg/kg is well tolerated, provides rapid reduction of existing H. longicornis tick infestations, and provides sustained residual protection for at least 35 days.

Indexed as

AcaricidesAnimalsDog DiseasesDogsFemaleIxodidaeMaleTick ControlTick InfestationsAcaricidesCredelioDogEfficacyHaemaphysalis longicornisLotilanerTicks

Identifiers

PMID30071885
PMCPMC6090816
OpenAlexW2886824964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.